Patent details

Basic Information

Publication number:

EP2976086

PCT Application Number:

US2014031442

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP147682678

PCT Publication Number:

WO2014153509

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION OF CATALYTIC MTORC 1/2 INHIBITORS AND SELECTIVE INHIBITORS OF AURORA A KINASE

French Title of Invention:

COMBINAISON D'INHIBITEURS CATALYTIQUES DE MTORC1/2 ET INHIBITEURS SÉLECTIFS DE LA KINASE AURORA A

German Title of Invention:

KOMBINATION AUS KATALYTISCHEN MTORC 1/2-INHIBITOREN UND SELEKTIVEN INHIBITOREN DER AURORA-A-KINASE

SPC Number:

Dates

Filing date:

21/03/2014

Grant date:

14/10/2020

EP Publication Date:

27/01/2016

PCT Publication Date:

25/09/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

14/10/2020

EP B1 Publication Date:

14/10/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

21/03/2021

Expiration date:

21/03/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

07/10/2020

 

 

Name:

Millennium Pharmaceuticals, Inc.

Address:

40 Landsdowne Street, Cambridge, MA 02139, United States (US)

Inventor

1

Name:

BRAKE, Rachel

Address:

United States (US)

2

Name:

NIU, Huifeng

Address:

United States (US)

Priority

Priority Number:

201361804314 P

Priority Date:

22/03/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/519; A61K 45/06; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

202042

Publication date:

14/10/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages